Amylyx Pharmaceuticals (AMLX) Exchange Rate Effect (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) recorded quarterly Exchange Rate Effect of -$111000.0 in Q1 2026, down 194.07% quarter-over-quarter from $118000.0 in Q4 2025, and down 156.35% on a YoY basis from $197000.0 in Q1 2025.
Amylyx Pharmaceuticals (AMLX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$111000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 156.35% year-over-year to -$111000.0; the TTM figure through Mar 2026 stood at $766000.0 (up 684.73% YoY), while the FY2025 annual figure was $1.1 million, up 345.21% from the prior year.
- Exchange Rate Effect was -$111000.0 for Q1 2026 at Amylyx Pharmaceuticals, down from $118000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $608000.0 in Q2 2025 to a low of -$525000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged $36470.6 across 5 years, with a median of -$18000.0 in 2023.
- Biggest YoY gain for Exchange Rate Effect was 5533.33% in 2022; the steepest drop was 18550.0% in 2022.
- A 5-year view of Exchange Rate Effect shows it stood at $507000.0 in 2022, then tumbled by 53.25% to $237000.0 in 2023, then slumped by 321.52% to -$525000.0 in 2024, then soared by 122.48% to $118000.0 in 2025, then slumped by 194.07% to -$111000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$111000.0 (Q1 2026), $118000.0 (Q4 2025), and $151000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Amylyx Pharmaceuticals | 1.51 Bn | 1.51 Bn | - | -111,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111,000.00 |
| Mar 31, 2026 | -111,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 608,000.00 |
| Jun 30, 2025 | 608,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Dec 31, 2024 | -525,000.00 |
| Dec 31, 2024 | -525,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | -110,000.00 |
| Mar 31, 2024 | -110,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Dec 31, 2023 | 237,000.00 |